The Current Ratio as of September 2024 (TTM) for Agios Pharmaceuticals, Inc. (AGIO) is 10.09

According to Agios Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.09. This represents a change of -14.58% compared to the average of 11.81 of the last 4 quarters.

Agios Pharmaceuticals, Inc. (AGIO) Historical Current Ratio (quarterly & annually)

How has AGIO Current Ratio performed in the past?

The mean historical Current Ratio of Agios Pharmaceuticals, Inc. over the last ten years is 8.65. The current 10.09 Current Ratio has changed 11.56% with respect to the historical average. Over the past ten years (40 quarters), AGIO's Current Ratio was at its highest in in the June 2021 quarter at 28.07. The Current Ratio was at its lowest in in the December 2017 quarter at 4.69.

Agios Pharmaceuticals, Inc. (AGIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Agios Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Agios Pharmaceuticals, Inc. (AGIO) Average Current Ratio

How has AGIO Current Ratio performed in the past?

The current Current Ratio of Agios Pharmaceuticals, Inc. (AGIO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Agios Pharmaceuticals, Inc. (AGIO) Current Ratio vs. Peers

How is AGIO’s Current Ratio compared to its peers?

Agios Pharmaceuticals, Inc.’s Current Ratio is greater than Mereo BioPharma Group plc (6.07), greater than Blueprint Medicines Corporation (3.71), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than BioMarin Pharmaceutical Inc. (3.05), less than IDEAYA Biosciences, Inc. (17.50), greater than AnaptysBio, Inc. (9.09), greater than MeiraGTx Holdings plc (2.36), less than Keros Therapeutics, Inc. (20.37), greater than Homology Medicines, Inc. (4.19), greater than Kymera Therapeutics, Inc. (8.45), less than Revolution Medicines, Inc. (15.42), greater than C4 Therapeutics, Inc. (5.09), greater than Nurix Therapeutics, Inc. (5.57), less than Relay Therapeutics, Inc. (15.64), greater than Stoke Therapeutics, Inc. (6.67), less than Pliant Therapeutics, Inc. (14.47), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Arvinas, Inc. (3.62), less than Syndax Pharmaceuticals, Inc. (10.50), greater than Cogent Biosciences, Inc. (9.25), less than Cullinan Oncology, Inc. (28.87), greater than KalVista Pharmaceuticals, Inc. (8.55), greater than Mersana Therapeutics, Inc. (2.72),

Build a custom stock screener for Agios Pharmaceuticals, Inc. (AGIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agios Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Agios Pharmaceuticals, Inc. (AGIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Agios Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.